Rybelsus(Oral Semaglutide)
The world's first oral GLP-1 medication. Rybelsus delivers the proven power of semaglutide in a convenient daily tablet — no injections required.
Key Features
Up to 6%
Weight Loss
Once Daily
Oral Tablet
No Needles
Tablet Form
MHRA Approved
Licensed Medicine
How Rybelsus Works
Rybelsus contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone produced in your gut after eating.
Reduces Appetite
Acts on appetite centres in the brain, helping you feel fuller sooner and reducing cravings and overall food intake.
Slows Gastric Emptying
Delays stomach emptying so food is digested more slowly, keeping you satisfied for longer between meals.
Improves Blood Sugar Control
Stimulates insulin release in response to food and reduces glucagon secretion, improving your body's glucose regulation.
Unique Oral Absorption
Contains SNAC (sodium salcaprozate), a specially designed absorption enhancer that allows semaglutide to pass through the stomach lining into your bloodstream.
Clinical Results
The PIONEER clinical trial programme demonstrated significant benefits for patients taking Rybelsus:
- Meaningful weight reduction — patients achieved approximately 3-5kg average weight loss alongside blood sugar improvements in clinical trials
- Real-world evidence suggests up to 5.7% body weight loss in individuals using oral semaglutide for weight management over 12 months
- Significant HbA1c reduction of up to 1.4% at the highest dose, improving long-term metabolic health
- Cardiovascular benefits — semaglutide has demonstrated reduction in major adverse cardiovascular events
Who Is Eligible?
Rybelsus may be suitable if you:
- Have a BMI of 27 or higher with weight-related health conditions
- Have a BMI of 30 or higher
- Prefer an oral tablet over injections
- Are committed to lifestyle changes including diet and exercise
- Have tried other weight loss methods without lasting success
Important: Rybelsus is an MHRA-licensed medication for Type 2 diabetes. Its use for weight management is prescribed off-label by our experienced clinicians following a thorough medical assessment. Not all patients will be suitable candidates.
Side Effects & Safety Information
Common Side Effects
Most side effects are mild to moderate and typically improve as your body adjusts to the medication:
- Nausea
- Diarrhoea
- Decreased appetite
- Vomiting
- Constipation
- Abdominal pain
- Indigestion
- Bloating
Serious Side Effects — Seek Medical Attention
- • Severe abdominal pain (possible pancreatitis)
- • Signs of thyroid tumours (lump in neck, hoarseness, difficulty swallowing)
- • Signs of kidney problems (changes in urination, swelling)
- • Severe allergic reactions (rash, swelling, difficulty breathing)
- • Vision changes (diabetic retinopathy complications)
- • Gallbladder problems (severe upper abdominal pain, jaundice)
Important Safety Information
- • Do not use if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN2 syndrome
- • Inform your doctor if you have a history of pancreatitis or kidney disease
- • May increase risk of hypoglycaemia when used with other diabetes medications
- • Not recommended during pregnancy or breastfeeding
- • Not suitable for patients with severe gastroparesis
Dosing & Administration
Standard Dosing Schedule
Rybelsus is gradually increased to minimise side effects and optimise results:
Month 1: 1.5mg once daily
Starting dose to help your body adjust — this is primarily a titration dose
Month 2+: 4mg once daily
First therapeutic dose where weight loss benefits begin
Month 3+: 9mg once daily (if needed)
Maximum dose for optimal results, based on individual response and tolerability
How to Take Rybelsus
- Take first thing in the morning on an empty stomach
- Swallow whole with no more than 120ml (half a glass) of plain water
- Do not crush, chew, or split the tablet
- Wait at least 30 minutes before eating, drinking, or taking other oral medications
- Store at room temperature (below 30°C) — no refrigeration needed
Why Choose Rybelsus?
🚫 No Injections
Perfect for patients who are needle-phobic or simply prefer the convenience of a daily tablet over weekly injections.
🌡️ No Refrigeration
Unlike injectable GLP-1 medications, Rybelsus tablets are stored at room temperature — ideal for travel and everyday convenience.
✅ Proven Science
Contains semaglutide — the same clinically proven active ingredient found in Wegovy and Ozempic, backed by extensive clinical trials.
💊 Simple Daily Routine
One tablet each morning fits easily into your daily routine. No weekly scheduling, no pen devices, no sharps disposal.
Frequently Asked Questions
Ready to Start Your Journey?
Take our health assessment to see if Rybelsus is right for you.